Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1
N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1
Inquiry
| Post Date: | Apr 16,2016 |
| Expiry Date: | Apr 16,2017 |
| Detailed Description: |
Cas No. :341031-54-7
Payment Method: Western Union, MoneyGram, T/T,Paypal,Bitcoin N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate MF： C22H27FN4O2.C4H6O5 MW： 532.566 CAS： 341031-54-7 Appearance: red powder Melting point: 189 ℃ ~ 191 ℃ Loss on drying: ≤1.0% Total impurities: ≤1.0% Content: 99% Packaging: 1kg aluminum foil bag or according to customer requirements Purpose: Sunitinib malate by blocking tumor cell growth to get blood and nutrients needed to play a therapeutic role. Clinical trials show that the drug can slow the growth rate of gastrointestinal stromal tumors and renal cell tumors can be reduced Size. Sunitinib malate is the first novel can be selectively targeted drugs against a variety of tyrosine kinase receptors, combined with the suspension of blood supply to the tumor cell anti-angiogenic and direct anti-tumor attack tumor cells Two mechanisms. It represents the advent of a new round of targeted therapies, both directly attack the tumor, nor conventional chemotherapy toxicity. Sunitinib malate indications are as follows: 1, imatinib mesylate between failure or intolerant gastrointestinal stromal tumors (GIST). 2, inoperable advanced renal cell carcinoma (RCC). 3, advanced pancreatic endocrine tumors. |
| CAS Registry Number: | 341031-54-7 |
| Synonyms: | ;SUNITINIB MALEATE;1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1);Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1);N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate;(2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1);Sunitinib Mablate; |
| Molecular Formula: | C28H38N4O7 |
| Molecular Weight: | 542.62392 |
| Molecular Structure: | 
|
| Company: | Guangzhou Quanao Chemical Co.,Ltd [ China ] |
| Contact: | Tracyxu |
| Tel: | +86-27-50756258 |
| Fax: | |
| Email: | tracy@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
